Improve balance using neurofeedback exergaming
- Trial ID
- NCT05986643
- Official Title
- Using Biofeedback During Exergaming to Attenuate Alpha Oscillations to Improve Postural Control in People Living With Parkinson's.
- Goal
- Improve balance using neurofeedback exergaming
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Leicester
- Study Type
- INTERVENTIONAL
- Enrollment
- 100 participants
- Conditions
- Parkinson Disease
- Interventions
- Exergame+Neurofeedback, Exergame [alone]
Plain-Language Summary
The goal is to improve postural control and reduce falls and freezing of gait, which are common and disabling problems in Parkinson's. The approach pairs balance-focused exergaming with real-time neurofeedback so people can see and learn to reduce alpha brain wave oscillations linked to attention and balance, with the hope that lowering those oscillations during movement will strengthen automatic postural responses. The study is looking for adults with mild-to-moderate Parkinson's who can stand and walk unaided (Hoehn and Yahr ≤4), who exercise less than recommended, have had at least one fall and one freezing episode in the past year, and are either on a stable dose of dopaminergic medication or untreated and not expected to start meds in the next three months; people with deep brain stimulators or other head metal implants, dementia, severe mobility limits, major medical issues that make exercise unsafe, or who need a walking aid are excluded.
Locations
- University of Leicester, Leicester, United Kingdom
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Exergame+Neurofeedback. The goal is to improve postural control and reduce falls and freezing of gait, which are common and disabling problems in Parkinson's. The approach pairs balance-focused exergaming with real-time neurofeedback so people can see and learn to reduce alpha brain wave oscillations linked to attention and balance, with the hope that lowering those oscillations during movement will strengthen automatic postural responses. The study is looking for adults with mild-to-moderate Parkinson's who can stand and walk unaided (Hoehn and Yahr ≤4), who exercise less than recommended, have had at least one fall and one freezing episode in the past year, and are either on a stable dose of dopaminergic medication or untreated and not expected to start meds in the next three months; people with deep brain stimulators or other head metal implants, dementia, severe mobility limits, major medical issues that make exercise unsafe, or who need a walking aid are excluded.
- Who can participate?
- Eligibility criteria vary. Check the full listing on ClinicalTrials.gov for detailed inclusion and exclusion criteria.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years and 10 months.